Register for free to listen to this article
Listen with Speechify
0:00
1:00
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. has introduced a new ThermoScientific Nunc 14 ml round bottom tube for critical cellular applications.Produced under ISO 13485 conditions with full lot traceability, each tube iscertified sterile (SAL 10-6), non-pyrogenic and USP Class VI tested to ensurecellular integrity and viability is effectively maintained for even the mostsensitive applications. Composed of optically clear polystyrene, the tube hasmolded graduations in 0.5 ml increments, allowing clear visualization foraccurately determining reagent volumes. The vent/close dual positionlow-density polyethylene cap provides the flexibility to switch between securemanual venting or an airtight seal. Each lot of the Nunc 14 ml round bottomtube is mouse embryo assay (MEA) tested and certified non-pyrogenic at lessthan 20 endotoxin units per device (0.5 endotoxin units per ml).
 
 
Thermo Fisher Scientific
(815) 968-0747
www.thermofisher.com
 

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue